You just read:

Janssen Pharmaceutica N.V. Announces Collaboration to Develop Diagnostic Biosignatures for Pre-Symptomatic Identification of Alzheimer's Disease

News provided by

Janssen Pharmaceutica N.V.

Dec 01, 2010, 09:00 EST